Search
This review supports the recommended use of palivizumab for reducing RSV-associated hospitalisation rates in premature babies born at gestational age <33 weeks.
The program was associated with a substantial decline in rotavirus attributable non-admitted AGE presentations to ED among children aged <5 years.
Data on asymptomatic identification rates of respiratory viruses are limited, particularly in Indigenous populations, who suffer a high burden of OM.
This large population-based study suggests a significant healthcare burden associated with influenza in children with a range of chronic lung diseases
Respiratory viruses, particularly respiratory syncytial virus and human metapneumovirus, are major contributors to pneumonia in Australian children
Given the beneficial effect of infant rotavirus vaccination efforts should be taken to optimize rotavirus vaccine coverage in those at highest risk
We aim to determine the contribute of bacteria and virus to childhood CAP to inform further development of effective strategies.
To assess the effects of systemic antibiotics for people with chronic suppurative otitis media.
Participants demonstrated a good understanding of safe prescribing and antimicrobial stewardship
A biologically active vaccine may produce a low measured vaccine efficacy under a range of epidemiological, vaccine-related and logistical conditions